DOSSIER · 13F-HR · Q1 2026

Vitruvian Partners LLP

$112M in tracked AUM across 7 positions as of Q1 2026.

VP
CIK 0001692590 · last filed Mar 31, 2026
Total AUM
$112M
as of Q1 2026
Holdings
7
positions
Whale Score
69
69
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Portfolio Overview

Vitruvian Partners LLP reported a significant contraction in portfolio value for the quarter ending September 30, 2025. The total assets under management (AUM) decreased by 60.3%, dropping from $164.22 million to $65.23 million. This substantial reduction in capital is not attributable solely to market performance but is largely driven by active capital deployment decisions, as evidenced by the exit of two major positions totaling approximately $96 million in value from t...

Key Holdings

The portfolio is dominated by a single "mega-position" in Marqeta, Inc. (MQ), which accounts for 55.47% of the total portfolio value ($36.18 million). This overwhelming allocation suggests that Vitruvian Partners has an extremely high conviction in the long-term prospects of this fintech company, or alternatively, is maintaining a core strategic stake while liquidating peripheral positions.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
HNGE
HINGE HEALTH INC
$48M1.3M43.1%
02
MQ
MARQETA
$28M6.9M25.0%
03
CARG
CARGURUS INC
$16M473K14.4%
04
XMTR
XOMETRY INC
$8M192K7.0%
05
M5216V106
GLOBAL-E
$6M210K5.8%
06
MXCT
MAXCYTE
$4M5.0M3.2%
07
RXST
RXSIGHT
$2M279K1.5%

Filing history

2026Q1Mar 31
$112M 19.6%
7 positionsView →
2025Q4Dec 31
$139M 113.3%
7 positionsView →
2025Q3Sep 30
$65M 60.3%
5 positionsView →
2025Q2Jun 30
$164M 112.5%
7 positionsLocked
2025Q1Mar 31
$77M 33.5%
5 positionsLocked
2024Q4Dec 31
$116M 54.9%
6 positionsLocked
2024Q3Sep 30
$257M 24.4%
6 positionsLocked
2024Q2Jun 30
$341M 8.0%
8 positionsLocked
2024Q1Mar 31
$315M 19.8%
8 positionsLocked
2023Q4Dec 31
$394M 11.6%
9 positionsLocked
2023Q3Sep 30
$353M 28.2%
10 positionsLocked
2023Q2Jun 30
$491M 5.0%
9 positionsLocked
Showing 12 of 30